THALES
8.7.2021 11:02:07 CEST | Business Wire | Press release
Car manufacturers require reliable connectivity and cybersecurity solutions to bring more convenience and secure services for drivers, passengers and automotive players. To build securely connected solutions and meet the requirements of new regulations such as UNECE WP29 *, carmakers can rely on Thales. With more than 20 years’ experience in automotive connectivity and cybersecurity, Thales is supporting them in the delivery of the trusted car of the future.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210708005033/en/
To offer users a safe and pleasant driving experience, connected car need to communicate with their environment, other vehicles, road infrastructure and the car makers’ network. Thales offers a secure connectivity solution to bring drivers, passengers and maintenance teams greater access to useful information. Connectivity is provided by wireless modules that transmit and/or receive data, through specific high-speed and low latency transmission. Furthermore, the connected car can have its own digital identity thanks to an automotive-grade embedded SIM (eSIM) to identify itself on the network and verify the integrity of the data it transmits. The eSIMs also simplify logistics since the connectivity service providers can be activated after the vehicle has been manufactured or any time during its lifetime.
* UNECE WP.29 is the United Nations Economic Commission for Europe (UNECE) World Forum for the Harmonization of Vehicle Regulations
This seamless connectivity management solution enables drivers and passengers to access a variety of global in-car services, such as eCall (automatic EU emergency call in case of an accident), remote software updates and smoother recall actions.
To ensure a high degree of security, Thales supports steadfast cyber security infrastructures through advanced consulting services , strong digital authentication and encryption mechanisms. This makes it possible to protect access to the car and the data it generates or receives, send secure updates and only allow access to authorized actors during the lifetime of a vehicle. Thales Security Operation Centres (SOC) further enable car manufacturers to keep a close eye on their fleet of vehicles, secure their data, and detect and respond immediately to potential cyber threats.
“Since connecting the very first car 25 years ago, Thales has been supporting car makers in their digital transformation to build and secure connected cars. Thales benefits from strong relationships with many car manufacturers and connectivity providers, enabling a thorough understanding of current needs and the market evolution. Today we are not only able to offer the car industry innovative connectivity solutions, but also to build together the best automotive cybersecurity solutions, so people can trust and rely on their vehicles.” Christine Caviglioli, VP Automotive at Thales
“By combining the cybersecurity expertise of Thales and the connectivity solutions from our digital business, Thales is positioned as a leader on the value chain of connectivity and cybersecurity to serve the automotive industry. Our ambition is to support Tier 1 suppliers and OEMs in accelerating their secure digital transformation and path towards fully autonomous vehicles.” Jean-Marie Letort, VP Cybersecurity, Consulting & Operations at Thales
In light of this unique always-on vehicle connectivity offer, Juniper Research recently presented Thales with its “2021 Best Automotive Connectivity Solution” award.
About Thales
Thales (Euronext Paris: HO) is a global leader in advanced technologies, investing in digital and “deep tech” innovations – connectivity, big data, artificial intelligence, cybersecurity and quantum computing – to build a confident future crucial for the development of our societies. The Group provides its customers – businesses, organisations and governments – in the defense, aeronautics, space, transport, and digital identity and security domains with solutions, services and products that help them fulfil their critical role, consideration for the individual being the driving force behind all decisions.
Thales has 81,000 employees in 68 countries. In 2020 the Group generated sales of €17 billion.
PLEASE VISIT
View source version on businesswire.com: https://www.businesswire.com/news/home/20210708005033/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release
If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids
Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release
Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use
DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release
-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom